ArticleJournal of imaging informatics in medicine2026
Automatic Localization and Classification of Crohn's Disease Activity in Computed Tomography Enterography Images Using Deep Learning.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Rapid and accurate localization and activity grading of Crohn's disease (CD) lesions on computed tomography enterography (CTE) images enhance the diagnostic efficiency of radiologists. We developed a one-stage model (called CD-YOLO) based on YOLOv5 for the automatic detection and classification of CD lesions. To tackle the challenges of variable sizes and shapes, and boundary blurring in CD lesions, we integrated a suite of specialized modules that not only enhanced the model's feature extraction capability but also enabled the effective fusion of multi-scale features. We retrospectively collected CTE images from 233 patients with pathologically and endoscopically confirmed CD. Patients were divided into training, validation, and testing cohorts at the patient level. The model performance was evaluated using the mAP@0.5, precision, and recall. Gradient-weighted class activation mapping (Grad-CAM) was employed to interpret the model predictions via visualization. The mAP@0.5 of CD-YOLO for detecting active and remission CD was 92.1% and 84.2%, respectively. Compared to YOLOv5s, the mAP@0.5 improved by 2.0% and 4.9% in detecting active and remission CD, respectively. Meanwhile, the missed detection and misdetection lesion rates decreased by 4.9% and 4.18%, respectively. The proposed CD-YOLO framework demonstrated superior performance in CD lesion localization and activity classification and may serve as an effective computer-aided diagnostic tool to support radiologists and gastroenterologists, as well as facilitate clinical teaching.
Indexed as
Identifiers
42192032What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.